ストックスクリーナーアプリを入手
1.71
5.56%
0.09
アフターアワーズ：
1.73
0.02
+1.17%
Invivyd Inc (IVVD) 最新ニュース
An Overview of Invivyd's Earnings - Benzinga
Invivyd (IVVD) to Release Earnings on Thursday - MarketBeat
Invivyd Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Invivyd (IVVD): Post-Data Plunge, Cash Runway And Next Catalysts For US Traders - AD HOC NEWS
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget
IVVD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How to listen to Invivyd's March 5 call on 2025 results - Stock Titan
New Invivyd staff get options on 192,000 shares at $1.69 each - Stock Titan
Invivyd (NASDAQ:IVVD) Earns "Buy" Rating from BTIG Research - MarketBeat
New study maps COVID protection to antibody levels, not variants - Stock Titan
Aug Breakouts: Is Eaton Vance Senior Income Trust gaining market share2025 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Lobbying Update: $20,000 of INVIVYD INC. lobbying was just disclosed - Quiver Quantitative
Invivyd (IVVD) CHRO Green sells $63k in stock after option exercise - Investing.com India
Invivyd (IVVD) CFO Duke sells shares worth $63,350 By Investing.com - Investing.com South Africa
Invivyd CSO Allen sells shares worth $58,600 By Investing.com - Investing.com Nigeria
Invivyd CSO Allen sells shares worth $58,600 - Investing.com South Africa
Invivyd (IVVD) CFO Duke sells shares worth $63,350 - Investing.com Australia
Invivyd (NASDAQ: IVVD) legal chief sells shares in tax sell-to-cover plan - Stock Titan
Invivyd (IVVD) HR chief logs RSU vesting and tax sell-to-cover sales - Stock Titan
Timothy Edward Lee Sells 19,663 Shares of Invivyd (NASDAQ:IVVD) Stock - MarketBeat
RA Capital discloses 9.99% Invivyd (IVVD) stake via shares and warrants - Stock Titan
BVF group discloses 9% Invivyd (IVVD) stake via shares and warrants - Stock Titan
Invivyd’s COVID antibody VYD2311 receives FDA fast track - MSN
Point72 discloses 6% Invivyd (IVVD) ownership in Schedule 13G/A - Stock Titan
Can Invivyd Inc. navigate macro headwindsMarket Performance Recap & Safe Capital Investment Plans - mfd.ru
Does Invivyd Inc. have a sustainable dividendEarnings Overview Summary & Safe Capital Preservation Plans - mfd.ru
What makes Invivyd Inc. stock attractive to growth funds2025 Retail Activity & Daily Profit Maximizing Trade Tips - mfd.ru
Invivyd, Inc. (NASDAQ:IVVD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Invivyd prices $125M stock offering at $2.50 per share - MSN
Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE) - The Globe and Mail
H.C. Wainwright reiterates Buy rating on Invivyd stock amid FDA feedback - Investing.com Nigeria
Invivyd receives FDA feedback on COVID antibody vs mRNA vaccine trial - Investing.com Nigeria
Invivyd receives FDA feedback on COVID antibody vs mRNA vaccine trial By Investing.com - Investing.com South Africa
Invivyd rises as FDA agrees with late-stage trial design for COVID-19 therapy - Seeking Alpha
Invivyd aligns with FDA for Phase 3 vaccine trial - Traders Union
Invivyd rises on late-stage trial testing COVID antibody against mRNA vaccines - TradingView
Invivyd, Inc. Announces FDA Alignment on LIBERTY Phase 3 Clinical Trial for VYD2311, a Monoclonal Antibody Candidate for COVID-19 Prevention - Quiver Quantitative
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration - The Manila Times
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 ... - Caledonian Record
FDA asks Invivyd to track myocarditis in new COVID antibody vs vaccine trial - Stock Titan
Invivyd Reports Strong Q3 Growth and Strategic Advances - MSN
Invivyd, Inc. (NASDAQ:IVVD) Short Interest Update - MarketBeat
Invivyd, Inc.'s (NASDAQ:IVVD) 26% Share Price Plunge Could Signal Some Risk - simplywall.st
Institutional investors in Invivyd, Inc. (NASDAQ:IVVD) see US$113m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
Invivyd shares edge higher on education campaign with Olympic star Lindsey Vonn - MSN
HC Wainwright Predicts Invivyd FY2030 Earnings - MarketBeat
0.11%
6.00%
大文字化:
|
ボリューム (24 時間):